- Datum04.04.2025
- Uhrzeit17:00 - 18:00 Uhr
- Veranstalter
XTB
WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083 Chart

Charts analysieren
wie die Profis?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse und handle direkt aus dem Chart bei Deinem Broker.
Chart analysieren
WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083 Realtime-Kurs
Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
---|---|---|---|---|---|---|
L&S | VK | |||||
Tradegate | VK | |||||
Stuttgart | VK |
Passende Produkte
WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
---|
Wertentwicklung (L&S)
Wikifolio
Passender Service zu WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083
Webinar zu WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083
Kursinformationen (L&S)
- Tagestief / Hoch (€)-
- 52W-Tief / Hoch (€)1,153-3,356
- Jahrestief / Hoch (€)1,964-3,356
- Schlusskurs (Vortag)
- Eröffnungskurs
Wichtigste Eigenschaften
Dividenden von WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083
Termine von WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083
- Aug25WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083Q2 2025 Earnings Release
- Mär31WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083Q4 2025 Earnings Release
- Aug24WUXI Biologics (Cayman) Inc. Registered Shares 0,0000083Q2 2026 Earnings Release
Beschreibung
WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.